EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
John Wiley & Sons, Inc.
WLY

WLY John Wiley & Sons, Inc.

John Wiley & Sons, Inc. · NYSE
Market Closed
47.03
▼ ⁦-0.44%⁩ (-0.21)
Market Cap$2.5B
Beta0.78
52w Low52w High
28.3857.45
Last Week
⁦-10.23%⁩
Last Month
⁦-12.34%⁩
Last 3 Months
⁦+12.89%⁩
Last Year
⁦+17.60%⁩
EL7 Factor Analysis
How we score this
Overall87
Excellent — top fifth of the marketSuper StockF 7/8Grey zoneBetter than 87% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
86
12.5x▲17.8xTop tier
▸
Growth
42
-0.3%▼7.1%Around median
▸
Quality
91
13.6%▲4.5%Top tier
▸
Safety
53
3.3x▼2.6xAround median
▸
Capital Return
39
2.92%▲2.12%Bottom tier
▸
Momentum
86
34.2%▲2.9%Top tier
▸
Sentiment
24
1▼3Bottom tier
Fair Value
Current price$47
Analyst target
No data
vs
DCF (estimate)
$61
⁦+30%⁩
Sees it clearly undervalued
⁦7.9⁩% discount · ⁦2⁩% growth

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target
—
Current Price $47.03
Average rating
★ 5.00
Strong Buy
Analyst coverage
1
Buy conviction
100%
High
Analyst ratings over time1 analysts rating
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months5.00 → 5.00
Recent analyst moves
  • ⬆ Upgrade2022-09-08
    CJS Securities
    Market OutperformOutperform
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    12.54x
    4.21x33.71x
    Very cheap
  • Forward P/E
    9.64x
    3.09x24.70x
    Very cheap
  • EV / EBITDA
    9.33x
    2.57x20.60x
    Cheap
  • FCF Yield
    10.1%
    -33.4%21.9%
    Strong
  • Revenue Growth YoY
    -0.3%
    -16.2%48.2%
    Below average
  • EPS Growth YoY
    110.7%
    -464.8%138.2%
    Strong
  • Gross Margin
    74.6%
    11.3%77.5%
    Strong
  • ROIC
    13.6%
    -33.6%17.7%
    Strong
  • Net Debt / EBITDA
    3.26x
    0.60x5.67x
    Low debt
  • Dividend Yield
    2.9%
    0.0%9.4%
    Moderate
  • Payout Ratio
    37.1%
    5.9%105.8%
    Moderate
  • Altman Z-Score
    2.07
    -8.274.77
    Strong
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-09-03 data

Company Overview

John Wiley & Sons, Inc. (WLY) operates in publishing research and educational content and licensing scientific data and knowledge. Its business model centers on the Research segment, which includes journal publishing, open access, and research solutions, and the Learning segment, which includes academic, professional, and digital content, course materials, and assessments. The company is expanding the monetization of its intellectual property through AI model training licenses, subscription-based knowledge feeds, clinical outcome assessment tools, and spectroscopy APIs.

In Q1 fiscal 2027, revenue was $386.4 million and gross profit was $285.5 million, while the company recorded a net loss of $11.7 million and a loss per share of $0.23. The Research segment generated revenue of $293 million, up 4%, and adjusted EBITDA of $87 million, up 9%, with its margin expanding 130 basis points to 29.6%. By contrast, Learning segment revenue fell 20% to $93 million, and its adjusted EBITDA was $14 million, with the margin declining to 15.1% from 27.4%.

The business mix showed a clear divergence in Q1 fiscal 2027: Research Publishing grew 12%, supported by $13 million from Emerald, open access growth, and AI licensing, while Research Solutions declined 30% due to the comparison with AI licensing revenue in the prior period. Within the Learning segment, Academic revenue fell 20% to $45 million, while Professional revenue also fell 20% to $48 million. For fiscal 2026, Wiley generated revenue of $1.7 billion, net income of $221.6 million, and earnings per share of $4.16.

What's Driving the Stock

  • Wiley generated AI revenue of $14 million in Q1 fiscal 2027, including $10.5 million from model training and $3.5 million from recurring sources, and contracted for an additional $14 million to be recognized across Q2 and Q3 fiscal 2027.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

Management is targeting more than $50 million in AI revenue in fiscal 2027, after it increased from $23 million in fiscal 2024 to $40 million in fiscal 2025 and then $49 million in fiscal 2026. The number of subscription-based knowledge feed customers reached 23 across five sectors, while the number of Nexus service partners increased to 71.
  • The Research business is supported by strong operating momentum; publishing submissions rose 31% and output increased 8%, while customer retention during the calendar 2026 journal renewal season remained above 99%. Research Publishing also grew 12%, or approximately 6% excluding Emerald, and gold open access output closed July 2026 at a record level.
  • Emerald added revenue of $13 million and adjusted EBITDA of $5 million in Q1 fiscal 2027. The acquisition cost was approximately $450 million net cash, and Wiley is targeting full annual savings of $30 million by year three, with a cumulative positive impact on earnings per share expected from year one.
  • Wiley launched spectroscopy APIs for corporate and academic laboratories, joined the U.S. Department of Energy's Genesis Mission as its only scientific publisher, and became a founding data partner in Cusp AI's AI Materials Foundry. Clinical outcome assessment revenue also more than tripled in Q1 fiscal 2027, after this business grew from $6 million in fiscal 2025 to $11 million in fiscal 2026.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +The Research segment has strong demand indicators, including 31% growth in publishing submissions, 8% growth in output, and customer retention above 99%, alongside a 130-basis-point increase in its adjusted margin to 29.6% in Q1 fiscal 2027.
    • +Wiley's scientific content is being converted into new revenue streams through model training, knowledge feeds, clinical outcome assessments, and spectroscopy; AI generated $14 million in Q1 fiscal 2027, with an additional $14 million contracted for the following two quarters.
    • +The Emerald acquisition expands Wiley's portfolio in economics, business, and finance, and it has already contributed $13 million in revenue and $5 million in adjusted EBITDA during the quarter. Management reports that integration is proceeding on or ahead of schedule, with a target of $30 million in annual savings by year three.
    • +Management reaffirmed its fiscal 2027 outlook, which includes low- to mid-single-digit organic growth, an adjusted EBITDA margin between 26.5% and 27.5%, adjusted earnings per share between $4.60 and $5.05, and free cash flow of $205 million.

    ▼ Selling Case6 pts

    • −The Learning segment represents the clearest area of operating weakness; its revenue fell 20% to $93 million in Q1 fiscal 2027, revenue from both the Academic and Professional businesses declined 20%, and its adjusted margin fell to 15.1% from 27.4%. Even excluding the AI licensing comparison, segment revenue declined by just under 10% due to weak demand for professional books and assessments and Amazon channel inventory pressures.
    • −AI licensing revenue remains volatile in timing; Q1 fiscal 2027 faced a comparison with $29 million recorded in the corresponding period, while revenue recognized in the quarter was $14 million. Reliance on large, irregular deals for part of the growth means quarterly results may fluctuate even as recurring revenue grows.
    • −The Emerald acquisition for approximately $450 million net cash increased net debt to EBITDA to 2.7 times, compared with 1.9 times a year earlier. Net interest expense also increased and pressured adjusted earnings per share, while the company expects Emerald to reduce free cash flow by approximately $15 million in fiscal 2027 before becoming a positive contributor in fiscal 2028.
    • −Wiley recorded a GAAP net loss of $11.7 million and a loss per share of $0.23 in Q1 fiscal 2027, compared with earnings per share of $0.22 in the corresponding period. Management attributed this shift primarily to restructuring, acquisition, and integration costs, while payments related to these items also increased by $14 million.
    • −Free cash flow was a cash use of $70 million in Q1 fiscal 2027, despite improving from a cash use of $100 million a year earlier. The company also plans to increase capital expenditures to approximately $80 million in fiscal 2027 from $65 million, making achievement of the $205 million annual free cash flow target more important.
    • −The analyst consensus on WLY is Neutral, not Buy, indicating that the market has not yet given broad support to the AI and data transformation thesis. The wide 52-week range between $28.38 and $57.4499 also reflects high sensitivity to changes in growth and margin expectations, and the available data does not include a consensus price target against which a fixed margin of safety can be measured.

    Valuation

    The analyst consensus on WLY is Neutral, and the available data does not include a consensus price target or a range of analyst targets, so a reliable comparison with a fixed target cannot be made. The 52-week range extends from $28.38 to $57.4499, while no displayed price-to-earnings ratio is available; this makes the stock's valuation dependent on the extent to which the adjusted earnings-per-share outlook of $4.60 to $5.05 for fiscal 2027 is achieved, and on the ability of Research and AI growth to offset Learning weakness and Emerald costs.

    Figures in the text are as of 2026-09-05; the live price is shown at the top of the page.

    FAQ

    How does Wiley generate revenue, and which was its largest segment in Q1 fiscal 2027?

    Wiley generates revenue from research and journal publishing, open access, research solutions, academic and professional content, assessments, and licensing content and data for AI. In Q1 fiscal 2027, the Research segment generated $293 million of the company's total revenue of $386.4 million, compared with $93 million for the Learning segment. The adjusted EBITDA margin in Research was 29.6%, compared with 15.1% in Learning.

    How large is Wiley's AI business in fiscal 2027?

    Wiley generated AI revenue of $14 million in Q1 fiscal 2027, split between $10.5 million from model training and $3.5 million in recurring revenue. It also contracted for an additional $14 million to be recognized across Q2 and Q3 fiscal 2027. Management is targeting more than $50 million for fiscal 2027, following $49 million in fiscal 2026 and $40 million in fiscal 2025.

    What impact has the Emerald acquisition had on Wiley's results and debt?

    Wiley acquired Emerald for approximately $450 million net cash in Q1 fiscal 2027, at approximately seven times adjusted EBITDA after accounting for targeted savings. Emerald added revenue of $13 million and adjusted EBITDA of $5 million in the quarter, but the acquisition increased net debt to EBITDA to 2.7 times from 1.9 times a year earlier. The company is targeting full annual savings of $30 million by year three and expects Emerald to become a positive contributor to free cash flow in fiscal 2028.

    Why did Wiley's Learning segment decline in Q1 fiscal 2027?

    Learning segment revenue fell 20% to $93 million, including $45 million from the Academic business and $48 million from the Professional business, with each down 20%. The Academic business was affected by a comparison that included $8 million in AI licensing revenue in the prior period and by a decline in print, despite growth in digital content and course materials. The Professional business also faced a comparison that included $5 million in AI licensing revenue, as well as weak consumer demand in retail, institutional demand for assessments, and Amazon inventory pressures.

    What is Wiley's outlook for fiscal 2027?

    On September 3, 2026, management reaffirmed its full fiscal 2027 outlook, including low- to mid-single-digit organic growth and mid-single-digit growth in the Research segment. It expects an adjusted EBITDA margin between 26.5% and 27.5%, compared with 26.2% in fiscal 2026. It also expects adjusted earnings per share between $4.60 and $5.05 and free cash flow of $205 million, with a contribution of $78 million from Emerald over 11 months excluded from the organic growth calculation.

    What are the key indicators of the strength of Wiley's research publishing franchise?

    Publishing submissions rose 31% and output increased 8% in Q1 fiscal 2027, while customer retention during the calendar 2026 journal renewal season remained above 99%. The Advanced portfolio includes more than 30 journals and generates revenue exceeding $70 million with strong double-digit growth, while 15 Wiley journals ranked first in their categories and 248 journals ranked among the top ten. In addition, 1,600 journals were migrated to the research publishing platform, and the Research segment margin increased 130 basis points to 29.6%.